Results 151 to 160 of about 1,662,601 (323)
Molecular Oncology, EarlyView.CD226+CD8+ T cells express elevated levels of RUNX2, exhibit higher proliferation capacity, cytokines and cytolytic molecules expression, and migratory capacity. In contrast, CD226−CD8+ T cells display an exhausted phenotype associated with the increased expression of co‐inhibitory receptors and impaired effector functions.
Maryam Rezaeifar +4 more
wiley +1 more source
NATURAL MUTATIONS IN INBRED LINES OF MAIZE AND THEIR HETEROTIC EFFECT. I. COMPARISON OF PARENT, MUTANT AND THEIR F1 HYBRID IN A HIGHLY INBRED BACKGROUND [PDF]
, 1954 Josef F Schuler
openalex +1 more source
Molecular Oncology, EarlyView.Triacsin C inhibition of the acyl‐CoA synthetase long chain (ACSL) family decreases multiple myeloma cell survival, proliferation, mitochondrial respiration, and membrane potential. Made with Biorender.com. Multiple myeloma (MM) is an incurable cancer of plasma cells with a 5‐year survival rate of 59%.
Connor S. Murphy +12 more
wiley +1 more source
Species and varieties; their origin by mutation
, 1906 Hugo de Vries, D. T. MacDougal
openalex +2 more sources
Blue-green caterpillars: The origin and ecology of a mutation in hemolymph color in Colias (Eurymus) philodice [PDF]
, 1922 John H. Gerould
openalex +1 more source
Molecular Oncology, EarlyView.Transient receptor potential melastatin‐4 (TRPM4) is overexpressed in prostate cancer (PCa). Knockout of TRPM4 resulted in reduced PCa tumor spheroid size and decreased PCa tumor spheroid outgrowth. In addition, lack of TRPM4 increased cell death in PCa tumor spheroids.
Florian Bochen +6 more
wiley +1 more source
A CASE OF MENDELIAN INHERITANCE COMPLICATED BY HETEROGAMETISM AND MUTATION IN OENOTHERA PRATINCOLA
, 1921 Frieda Cobb
openalex +2 more sources
Cell‐free DNA aneuploidy score as a dynamic early response marker in prostate cancer
Molecular Oncology, EarlyView.mFast‐SeqS‐based genome‐wide aneuploidy scores are concordant with aneuploidy scores obtained by whole genome sequencing from tumor tissue and can predict response to ARSI treatment at baseline and, at an early time point, to ARSI and taxanes. This assay can be easily performed at low cost and requires little input of cfDNA. Cell‐free circulating tumor
Khrystany T. Isebia +17 more
wiley +1 more source
Measurements of rate of mutation of flagellar antigenic phase inSalmonella typhi-murium [PDF]
, 1949 B. A. D. Stocker
openalex +1 more source